Skip to main content
. 2018 Apr 24;9(31):21921–21929. doi: 10.18632/oncotarget.25119

Figure 2. Histopathological examination of the H&E-stained sections for each tumor area sampled and the corresponding molecular data in the 3 CLM with genetic heterogeneity.

Figure 2

Figure 2

Figure 2